Document is current

Article History

Received: 14 April 2024

Accepted: 25 April 2024

First Online: 9 May 2024

Declarations

:

: The authors assert that all procedures contributing to this study comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. The study has been approved by the University Ethical Review Authority (937/28.11.2023). Potential protocol modifications will be described in detail on clinicaltrials.gov (ID: NCT06262464). Any modification will be informed on Clinicaltrials.gov.Regarding participants’ consent, participants will be informed about the basics of the study and the potential benefits. Informed consent of the participants will be obtained after the nature of the procedures has been fully explained. Only those who provide the consent will be included in the study. They will also be reminded that they can withdraw their consent at any point to terminate their participation and that anonymity and confidentiality are ensured. Regarding the potential risks of the study, no risks are expected. Nevertheless, in case of adverse events (e.g. relevant clinical symptoms) individualized assistance will be offered. If necessary, specialized services will be provided.

: Not applicable.

: The authors declare that they have no competing interests.